USPTO serial 88925587
COVAGUARD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GOODWIN, KATRINA JOYE
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with COVAGUARD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SETH A. ROSE
SETH A. ROSE LOEB & LOEB LLP321 NORTH CLARK STREET, SUITE 2300CHICAGO, IL 60654UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for use in manufacturing of antimicrobial preparations to prevent against microorganisms on the finished article; chemical surface coating compositions for industrial use, namely, for use in the manufacture of medical, surgical, laboratory and diagnostic test devices and equipment, biomatrices, orthopaedic implants, sutures, catheters, IV lines, and haemodialysis lines; chemical surface coating compositions for industrial use, namely, for use in the manufacture of antimicrobial coatings for medical, surgical, laboratory and diagnostic test devices and equipment, biomatrices, orthopaedic implants, sutures, catheters, IV lines, and haemodialysis lines; chemical surface coating compositions for industrial use, namely, for use in the manufacture of bed sheets, towels of textile, clothing, tents; chemical surface coating compositions for industrial use, namely, for use in the manufacture of textiles; chemical surface coating compositions for industrial use, namely, for use in the manufacture of antimicrobial coatings for textiles; chemical preparations for use in the manufacture of adhesives having a protective barrier against microorganisms | ABANDONED | — |
| 005 | Antimicrobial preparations for creating a protective barrier against microorganisms; antimicrobial spray liquid for creating a protective barrier against microorganisms; antimicrobial gel for creating a protective barrier against microorganisms; antimicrobial aerosol for creating a protective barrier against microorganisms; antimicrobial cream for creating a protective barrier against microorganisms; articles impregnated or coated with antimicrobial preparations for creating a protective barrier against microorganisms, namely, tissues and disposable sanitizing wipes, bandages for skin wounds, surgical bandages, medical and surgical dressings, dressings for catheter insertion sites, dressings for chronic ulcerated wounds, dressings for severe burns, adhesion-prevention dressings; antimicrobial adhesives for medical applications, namely, for adhering wound dressings to the skin, for adhering dressings for catheter insertion sites, for securing surgical and medical apparatus to the skin, and for application to medical and surgical devices for localized delivery of active pharmaceutical ingredients; antimicrobial medical adhesives for use in surgery; antimicrobial medical adhesives for binding internal and external tissue and wounds; antimicrobial adhesives for wound dressing; antimicrobial sanitizing sprays for coating hard surfaces including table tops, counter tops, door knobs, doors, chairs for personal use; bone cement for orthopedic purposes; urine drug test kits namely drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of drugs; urine pregnancy test kits namely pregnancy test kits for home use; saliva drug test kits namely drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of drugs; saliva alcohol test kits namely drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of alcohol; cholesterol and blood glucose test; In vitro diagnostic accessories | ABANDONED | — |
| 010 | Medical, surgical, and diagnostic test devices for testing for viruses having a protective barrier against microorganisms; Medical, surgical, and diagnostic test devises having a protective barrier against microorganisms, namely, anatomical bandages for joints, compression bandages, elastic bandages, hernia bandages, support bandages, non-invasive ECG and EEG electrodes and leads, implantable electrodes in the nature of a cortical electrodes, defibrillator, pacemaker, and stimulator; reusable surgical instruments; single-use scalpels; forceps for medical use; biopsy needles; syringe needles for medical purposes; needles used for suturing and absorbable and non-absorbable sutures; infusion, brain, coronary, and ventricular cannulas; intra-ocular lenses; enteral feeding pump tubes; tracheal feeding tubes; tubing specifically adapted for use with infusion pumps; nasal gastric tubes; liquid and gas-flow tubes, namely, epidural and spinal catheters; artificial hip implants; artificial maxillo-facial implants; artificial implantable staples in the nature of a medical device; prosthetic joint replacements in the nature of artificial joints; annuloplasty ring; implantable drug deliver, namely, fallopian tube and vas deferens clip and band contraceptive devices; embolization prevention implants in the nature of contraceptive devices; cardiovascular drug delivery patches sold without medication; intracardiac patch prostheses; mammary prostheses; vascular prostheses; infusion ports in the nature of pumps; infusion port catheters; suction catheters; angiography catheters; cardiac catheters; cerebrospinal catheters; hydrocephalic catheters; intravascular catheters; ventricular neurological catheters; vascular perfusion catheters; cardiovascular stents; iliac stents; biliary, intermittent, abscess, and thoracic surgical drains; cerebrospinal surgical drains; carotid artery shunts; blood testing apparatus, namely, blood collection tubes; orthopaedic implants made of artificial materials; sutures; catheters; IV lines and haemodialysis lines in the nature of intravenous tubes for feeding fluids; Masks for use by medical personnel, medical gloves for use by medical personal, medical gowns, surgical gowns, patient examination gowns, hospital scrubs in the nature of pants and tops, all the foregoing impregnated or coated with antimicrobial preparations for creating a protective barrier against microorganisms | ABANDONED | — |
| 040 | Manufacturing process consulting services in the field of how to apply antimicrobial surface coatings and impregnating materials with antimicrobial preparations; manufacturing process consulting services in the field of antimicrobial additives in manufacturing processes; contract manufacturing services applying antimicrobial surface coatings and impregnating materials with antimicrobial preparations; contract materials processing services applying antimicrobial surface coatings and impregnating materials with antimicrobial preparations | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Covalon Technologies Ltd.
- Other trademarks owned by Covalon Technologies Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Similar marks named COVAGUARD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Nov 4, 2026 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Nov 4, 2026 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Nov 4, 2026 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Jul 15, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Jul 14, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 14, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 24, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 18, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 18, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 17, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 1, 2025 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 1, 2025 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 1, 2025 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Aug 7, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 6, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 6, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 20, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 20, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 20, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 5, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 9, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2024 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 16, 2023 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 16, 2023 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 16, 2023 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Oct 5, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 2, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 2, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 2, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2023 | ALIE | ASSIGNED TO LIE | — |
| Nov 22, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 24, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| May 24, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| May 24, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 11, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 16, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 16, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 16, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 9, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 19, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 18, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 23, 2020 | NWAP | NEW APPLICATION ENTERED | — |